Saba Capital Management, L.P. bought HQL
April 24, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 20,529 shares of Abrdn Life Sciences Investors at $13.12 per share, a transaction worth $269.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,529
Price
$13.12
Total value
$269.3K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 24, 2024
Filing dateApril 26, 2024
Shares owned after2,807,724
OwnershipIndirect
10b5-1 planNo
AmendedNo